The UK will launch a “Precision Medicine Catapult” next year as part of the government’s commitment to spend 5.9 billion pounds ($9.3 billion) on its science and innovation strategy from 2015-21.

The plan also pledges to create a National Formulation Centre to help U.K. companies develop medicines and chemicals that are deemed too high risk or technically challenging.

The Catapult centers aim to bring universities and businesses together to spur innovation and support emerging companies. The UK already has seven catapults, including one dedicated to cell therapies.